Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.

To compare the efficacy and safety of adjunct pergolide therapy versus bromocriptine in patients with Parkinson's disease, already established on levodopa and suffering the long-term complications of therapy.